311 related articles for article (PubMed ID: 37402856)
21. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
24. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
25. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
[TBL] [Abstract][Full Text] [Related]
26. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.
Manosso LM; Arent CO; Borba LA; Ceretta LB; Quevedo J; Réus GZ
Cells; 2021 Aug; 10(8):. PubMed ID: 34440767
[TBL] [Abstract][Full Text] [Related]
27. Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis.
Chan D; Karimi S; Follows G; Torpey N; Suchanek O
CEN Case Rep; 2023 Feb; 12(1):27-31. PubMed ID: 35729310
[TBL] [Abstract][Full Text] [Related]
28. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature.
Vakili K; Fathi M; Yaghoobpoor S; Sayehmiri F; Nazerian Y; Nazerian A; Mohamadkhani A; Khodabakhsh P; Réus GZ; Hajibeygi R; Rezaei-Tavirani M
Front Cell Infect Microbiol; 2022; 12():983089. PubMed ID: 36619768
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
30. Pityriasis Rosea after COVID-19 Infection.
Prtajin M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
[TBL] [Abstract][Full Text] [Related]
31. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
32. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Brahma S; Naik A; Lordan R
Clin Nutr ESPEN; 2022 Oct; 51():17-27. PubMed ID: 36184201
[TBL] [Abstract][Full Text] [Related]
33. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.
Gold JE; Okyay RA; Licht WE; Hurley DJ
Pathogens; 2021 Jun; 10(6):. PubMed ID: 34204243
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
35. [Reactivation of Epstein-Barr virus (
Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
[TBL] [Abstract][Full Text] [Related]
36. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal symptoms in COVID-19: the long and the short of it.
Freedberg DE; Chang L
Curr Opin Gastroenterol; 2022 Nov; 38(6):555-561. PubMed ID: 36165028
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
Johnson SD; Olwenyi OA; Bhyravbhatla N; Thurman M; Pandey K; Klug EA; Johnston M; Dyavar SR; Acharya A; Podany AT; Fletcher CV; Mohan M; Singh K; Byrareddy SN
World J Gastroenterol; 2021 Aug; 27(29):4763-4783. PubMed ID: 34447225
[TBL] [Abstract][Full Text] [Related]
39. Pediatric inflammatory multisystem syndrome induced Panuveitis associated with SARS-CoV- 2 infection: What the Ophthalmologists need to know.
Merticariu CI; Merticariu M; Cobzariu C; Mihai MM; Dragomir MS
Rom J Ophthalmol; 2022; 66(2):198-208. PubMed ID: 35935086
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 alters human microbiomes: a meta-analysis.
Reuben RC; Beugnon R; Jurburg SD
Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
